<DOC>
	<DOCNO>NCT01476215</DOCNO>
	<brief_summary>This proof principle PK study allow GSKCH select favorable sustained release formulation among 3 prototype move next stage drug development .</brief_summary>
	<brief_title>A Pharmacokinetic Study Investigating Rate Extent Paracetamol Absorption Three Experimental Sustained Release Pediatric Suspensions</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Healthy volunteer Body Mass Index 19.0 28.0 ( kg/m2 ) inclusive</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>paracetamol</keyword>
</DOC>